Assessing the effect of serum therapy on decreasing of icterus
Phase 3
- Conditions
- eonatal jaundice.Neonatal jaundice from other and un specified causes
- Registration Number
- IRCT201012295497N1
- Lead Sponsor
- Vice chancellor for research, Hamedan University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
1.Term neonate (between 37 and 42 weeks of neonatal age ). 2. All neonates between 2 and 28 days of old age
3. 17< total serum bilirubin <25 .
4. 2500 g < weight< 4000 g 5. Without congenital anomaly and systemic diseases (sepsis, anemia, hemolysis, HMD). Exclusion criteria: 1. Neonate <37 weeks of old age 2. Congenital anomaly, systemic disease (sepsis, HMD. pneumonia, anemia, hemolysis) 3.Demand to blood exchange 4. 4000 g <Weight< 2500 g . 5. Neonates who in first ten days of life loss more than 3% of weight.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Indirect bilirubin. Timepoint: During at 6, 12, 24, 48 and 72 hours after beginning of phototherapy. Method of measurement: Measuring serum bilirubin(diazo method).
- Secondary Outcome Measures
Name Time Method Age. Timepoint: Between 2 and 28 days of old age. Method of measurement: Since birthday.;Duration of hospitalization. Timepoint: 6- 12- 24- 48 and 72 hours after phototherapy. Method of measurement: Hours.;Sex. Timepoint: Beginning of study. Method of measurement: Physical examination.;Blood group. Timepoint: Beginning of study. Method of measurement: Laboratory test.